Picture of Centessa Pharmaceuticals logo

CNTA — Centessa Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Centessa Pharmaceuticals Reports Fourth Quarter Net Loss Of $0.68 Per Share

March 30 (Reuters) - Centessa Pharmaceuticals PLC  260y.F :
    * CENTESSA PHARMACEUTICALS REPORTS FOURTH QUARTER AND 2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * CENTESSA PHARMACEUTICALS PLC - COMPANY EXPECTS CASH AND
CASH
EQUIVALENTS WILL FUND OPERATIONS INTO EARLY 2024
    * CENTESSA PHARMACEUTICALS PLC - QTRLY NET LOSS PER ORDINARY
SHARE
- BASIC AND DILUTED $0.68

Source text for Eikon:  ID:nGNX8WdLNN 
Further company coverage:  260y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Centessa Pharmaceuticals

See all news